The competitive status of the U.S. pharmaceutical industry : the influences of technology in determining international industrial competitive advantage / / prepared by the Pharmaceutical Panel Committee on Technology and International Economic and Trade Issues, Office of the Foreign Secretary National Academy of Engineering, Commission on Engineering and Technical Systems National Research Council ; Charles C. Edwards, chairman ; Lacy Glenn Thomas, rapporteur |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Washington, D.C. ; ; [Great Britain], : National Academy Press, 1983 |
Descrizione fisica | 1 online resource (114 p.) |
Disciplina | 338.4761510973 |
Altri autori (Persone) | EdwardsCharles C |
Soggetto topico |
Pharmaceutical industry - Technological innovations - United States
Pharmaceutical industry - United States Competition - United States Drugs - United States - Marketing |
ISBN |
1-280-24696-0
9786610246960 0-309-57203-7 0-585-21783-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
The Competitive Status of the U.S. Pharmaceutical Industry -- Copyright -- Preface -- Contents -- Summary -- FINDINGS ON THE U.S. COMPETITIVE POSITION -- DETERMINANTS OF NATIONAL PHARMACEUTICAL COMPETITIVE ADVANTAGE -- OPTIONS FOR AMERICAN POLICY -- Trade Options -- Domestic Economic Options -- Regulatory Options -- 1 Overview of U.S. Pharmaceutical Industry -- EMERGENCE OF THE MODERN PHARMACEUTICAL INDUSTRY -- NATURE OF PHARMACEUTICAL COMPETITION -- BENEFITS AND RISKS OF TECHNICAL CHANGE -- OVERVIEW AND LIMITATIONS OF THIS STUDY -- NOTES -- 2 Competitive Position of the U.S. Pharmaceutical Industry -- RESEARCH -- INNOVATION -- PRODUCTION -- SALES -- STRUCTURE -- TRADE -- SUMMARY -- NOTES -- 3 Determinants of National Pharmaceutical Competitive Advantage -- LABOR COSTS -- MARKET GROWTH -- NATIONAL SCIENTIFIC CAPACITY -- GENERAL RELATIVE DECLINE OF U.S. INDUSTRY -- INDUSTRIAL POLICY: REGULATION -- Greater Use of Expert Committees -- Greater Acceptance of Foreign Data -- Less Politicization of Drug Approval Process -- Greater Cooperation between Regulators and Industry -- INDUSTRIAL POLICY: TAXATION -- INDUSTRIAL POLICY: TRADE -- SUMMARY -- NOTES -- 4 New Developments Affecting the Industry -- SCIENTIFIC ADVANCES -- JAPANESE DEVELOPMENTS -- NOTES -- 5 Options for American Industrial Policy -- TRADE OPTIONS -- DOMESTIC ECONOMIC OPTIONS -- REGULATORY OPTIONS -- The IND Process -- Early Clinical Research -- Objectives of Investigational Drug Regulation -- Clinical Development Studies -- Preclearance of Clinical Research -- The NDA Process -- Application of the Standards for Drug Approval -- The NDA Submission and Its Review -- Utilization of Outside Expert Advice -- Application of the Standards for Drug Approval -- FDA Management -- Resources for the New Drug Review Process -- Improving Interactions with Industry.
Tracking the Review Process to Ensure Timeliness -- Conflict of Interest and Expert Advisers -- Improving Interactions with Industry -- NOTES -- 6 Biographical Sketches -- Index. |
Record Nr. | UNINA-9910817036303321 |
Washington, D.C. ; ; [Great Britain], : National Academy Press, 1983 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Electronic prescribing : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, second session, July 22, 2004 |
Descrizione fisica | 1 online resource (iii, 48 p.) : ill |
Soggetto topico |
Internet pharmacies - Standards - United States
Drugs - Prescribing - Standards - United States Pharmaceutical industry - Technological innovations - United States Medicare - Information technology |
Soggetto non controllato |
Drugs
Pharmaceutical industry Medicare Medical Business & economics |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Electronic prescribing |
Record Nr. | UNINA-9910693941303321 |
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Point, click, self-medicate : a review of consumer safeguards on Internet pharmacy sites : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, March 27, 2003 |
Descrizione fisica | 1 online resource (iii, 150 p.) : ill |
Altri autori (Persone) | BealesJ. Howard |
Soggetto topico |
Internet pharmacies - Government policy - United States
Internet marketing - Government policy - United States Consumer protection - United States Electronic commerce - Government policy - United States Pharmaceutical industry - Technological innovations - United States Witnesses, FTC |
Soggetto non controllato |
Internet marketing
Consumer protection Electronic commerce Pharmaceutical industry Internet United States Technological innovations Business & economics Law Technology & engineering |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Point, click, self-medicate |
Record Nr. | UNINA-9910689669903321 |
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Research and development in the pharmaceutical industry [[electronic resource]] |
Pubbl/distr/stampa | [Washington, D.C.] : , : Congress of the U.S., Congressional Budget Office, , [2006] |
Descrizione fisica | vii, 55 pages : digital, PDF file |
Collana | A CBO study |
Soggetto topico |
Pharmaceutical industry - Research - United States
Pharmaceutical industry - Technological innovations - United States |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910695329903321 |
[Washington, D.C.] : , : Congress of the U.S., Congressional Budget Office, , [2006] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|